ADVERTISEMENT
for patients with her genetic profile,” she told Maxwell. “It’s almost as if the treatment was created for someone exactly like Emily.”
That sentence stayed with him.
Nexus Biotech.
The trial treatment came from Nexus Biotech.
A company Bennett Industries had funded three years earlier.
A company William Harrington had championed aggressively.
A company continue reading …
ADVERTISEMENT